Viessmann, a purpose-driven family company, completed the acquisition of a minority stake in schülke, a company specialised in infection prevention and treatment. Financial terms were not disclosed. “schülke is a pioneer in the prevention of infectious diseases, which pose an ever-increasing health risk for future generations due to the increasing spread of pathogenic bacteria and virus vectors. Setting new sustainability and innovation standards in the healthcare industry, schülke contributes directly to our purpose of co-creating living space for generations to come. By joining schülke’s shareholder consortium, we provide our expertise to optimally support the company’s mission of protecting lives worldwide,” Boris Scukanec Hopinski, Viessmann COO.